USDA's FSIS and FDA released a formal agreement to address the regulatory oversight of human food products derived from the cells of livestock and poultry, which describes the oversight roles and responsibilities for both agencies and how they will collaborate to regulate the development and entry of these products into commerce.
A new final rule amends the AMS regulations regarding a fresh mango national research and promotion program to include frozen mangos as a covered commodity under the Mango Promotion, Research and Information Order.
The USDA's National List of Allowed and Prohibited Substances (National List) for organic regulations has been amended to implement recommendations submitted to the secretary of agriculture by the NOSB.
Meat processors who brushed up on the latest labeling guidelines at the International Production & Processing Expo learned details about when bioengineered logos might be needed and how FDA’s nutritional panel updates might trickle over to their products.
The FDA has proposed to amend its regulation that defines "biological product" to incorporate changes made by the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), and to provide its interpretation of the statutory terms "protein" and "chemically synthesized polypeptide."
The FDA has announced the withdrawal of the proposed rule on "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products," published in the Federal Register of Nov. 13, 2013.